English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Adverse Drug Reactions ( ADRs ) pose a challenge for medical doctors ( MDs ) and other healthcare professionals ( HCPs ). Serious  ADRs  increase patient morbidity and mortality and generate a large financial footprint on healthcare costs.Statistics show that about 6% of hospitalizations are due to  ADRs  and over 50% of them could be avoided. Two years after introducing the pharmacovigilance ( PhV ) requirements in the European Union, national regulatory  PhV  requirements were published in the Bulgarian pharmaceutical legislation. Nonetheless,  MDs ‘ awareness of the  PhV  topic still remains extremely important due to patient safety.Spontaneous reporting of  ADRs  is essential to the success of a pharmacovigilance program. Underreporting of  ADRs  is common, especially among  MDs  and  HCPs .This study aims to analyse the attitude and the knowledge of graduated  MDs  towards the reporting of  ADRs  and drug safety in general. In addition, the study aims to examine their opinion, attitude, and recommendations so that reporting of  ADRs  becomes more regular.

Attitude of medical doctors to adverse drug reactions reporting in Bulgaria